In Brief: PhRMA
Executive Summary
PhRMA: Alixe Glen to join the Pharmaceutical Research & Manufacturers of America as VP-public affairs in May, the association announces March 17. Glen, who will have responsibility for communications and advertising, is currently senior VP-communications for Blue Cross/Blue Shield; she has also served as assistant secretary of public affairs at HHS and deputy press secretary in the Bush White House. Glen's familiarity with national media is designed to increase the association's posture and visibility. Glen will succeed VP-Communications Jeffrey Warren, who is retiring after 18 years...
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth